Imaging and clinical correlates with regorafenib in metastatic colorectal cancer

Imaging is a key clinical tool used to evaluate tumor burden and response to treatment across tumor types [1]. In colorectal cancer (CRC), imaging plays an important role in determining tumor stage and prognostic characteristics, selecting appropriate treatment strategies, and in assessing response to systemic therapy and disease recurrence [2 –4]. In solid tumors, response to therapy is typically measured using Response Evaluation Criteria in Solid Tumors (RECIST), which was developed for clinical trials to measure tumor response to chemotherapy in a standard and reproducible way [1,5].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Tumour Review Source Type: research